The 12th Outsourcing in Clinical Trials UK & Ireland conference will focus on the region’s future as a clinical trials hub.

The FDA ordered a clinical hold on Rocket Pharmaceuticals' Danon disease trial after the adverse event was first disclosed.

Augustine Therapeutics has initiated subject dosing in the randomised Phase I trial of AGT-100216 for Charcot-Marie-Tooth ...

With the 78th World Health Assembly ending today, all eyes have been on this year’s World Health Organization (WHO) member’s ...

Huonslab has concluded enrolment of subjects in the Phase I clinical trial, a significant step in the development of the ...

PYC Therapeutics has concluded the first cohort dosing of healthy volunteers in the Phase Ia SAD trial of its drug candidate ...

Gilead Sciences’ randomised, global Phase III ASCENT-03 trial of Trodelvy (sacituzumab govitecan-hziy) has met its primary ...

Mineralys has reported outcomes from its pivotal randomised, placebo-controlled Phase III Launch-HTN trial assessing ...

Prothena Corporation’s Phase III AFFIRM-AL trial of birtamimab in individuals with AL amyloidosis misses its primary endpoint ...

ANI Pharmaceuticals has commenced a Phase IV trial to compare two dosage levels of Purified Cortrophin Gel for acute gout ...

At CTO West Coast, an expert discussed the implications of the FDA’s expedited approval programmes with a spotlight on ...

Astellas and Pfizer's Xtandi plus ADT showed a decrease in mortality risk in a metastatic hormone-sensitive prostate cancer ...